Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon Safety and Efficacy in Chronic Insomnia
NCT00237497Phase 3Completed
- Sponsor
- Takeda
- Start
- Jul 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramelteon in Insomnia, sponsored by Takeda. Started Jul 2005; status: completed.
02
Drugs
ramelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00237497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237497.